Endocrinology News and Research

Latest Endocrinology News and Research

Scientists find way to block androgens, halt tumor progression in prostate cancer

Prostate cancer advances when tumors become resistant to hormone therapy, which is the standard treatment for patients, and begin producing their own androgens. Researchers at UT Southwestern Medical Center have found that blocking one of the enzymatic steps that allow the tumor to produce androgens could be the key in halting a tumor's growth.

21 Jul 2010

Lannett's ANDA for Phentermine Hydrochloride Blue/White Seed Capsules receives FDA approval

Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Phentermine Hydrochloride Blue/White Seed Capsules USP, 30 mg, the generic equivalent of Sandoz, Inc.'s Reference Listed Drug (RLD) Phentermine Hydrochloride Capsules USP, 30 mg.

21 Jul 2010

FDA accepts MannKind's resubmission of AFREZZA NDA, sets PDUFA action date

MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.

21 Jul 2010

Forest Laboratories reports first-quarter diluted EPS of $0.39

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.39 in the first quarter of fiscal 2011. Excluding the charge related to the United States Department of Justice investigations described below, and a charge of $50.0 million, or $0.17 per share net of tax, for a new product licensing fee, non-GAAP earnings per share for the first fiscal quarter were $0.95 per share.

20 Jul 2010

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.

20 Jul 2010

Johnson & Johnson second-quarter sales increase 0.6% to $15.3 billion

Johnson & Johnson today announced sales of $15.3 billion for the second quarter of 2010, an increase of 0.6% as compared to the second quarter of 2009. Operational results increased 0.1% and the positive impact of currency was 0.5%. Domestic sales declined 2.8%, while international sales increased 4.1%, reflecting operational growth of 3.0% and a positive currency impact of 1.1%.

20 Jul 2010

More than half of parents interested in using at-home personal genetic testing for their children: Poll

The latest results from the C.S. Mott Children's Hospital National Poll on Children's Health show more than half of parents are interested in having their children checked for disease risks using at-home personal genetic testing kits.

20 Jul 2010

Researchers reveal findings on restricted lineage of iPS cells

Adult cells that have been reprogrammed into induced pluripotent stem cells (iPS cells) do not completely let go of their past, perhaps limiting their ability to function as a less controversial alternative to embryonic stem cells for basic research and cell replacement therapies, according to researchers at Children's Hospital Boston, John Hopkins University and their colleagues

20 Jul 2010

Michelangelo hides image of human brainstem in 'Separation of Light from Darkness' panel

Detailed analysis of Michelangelo's Sistine Chapel frescoes reveals a secret that's been hidden for 500 years: an image of the human brainstem in a panel showing God at the beginning of Creation, according to an article in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

20 Jul 2010

Jinfiniti Biosciences moves from clinical studies to developing biomarkers

A new biotech company has grown out of laboratory and clinical studies at the Medical College of Georgia with the goal of improving the diagnosis and treatment of diabetes and cancer.

20 Jul 2010

Novo Nordisk completes patient enrollment in A1chieve study for type 2 diabetes management

Today, Novo Nordisk announced the landmark recruitment of the 60,000th patient in the A1chieve(R) study - an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.

From Novo Nordisk 20 Jul 2010

Scientists find major shortcomings in assessing CVD risk in HIV patients

At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus, two international meetings of HIV/AIDS scientists and patient advocates find major shortcomings in the design and analysis of studies used to assess cardiovascular disease risk in people with HIV with significant implications for improving medical care.

20 Jul 2010

Responding to access-to-care challenges: Ideas from a rural doctor, a Washington, D.C. hospital

Evansville (Ind.) Courier & Press reports on the struggles rural physicians face in providing care by focusing on Dr. Lloyd "Pat" McGinnis, a family medicine and geriatrics specialist who was "one of only five doctors in Spencer County, a rural area of Southwestern Indiana. … Doctors throughout the country are struggling with the same issues of providing quality care to patients with limited incomes in an environment of uncertainly as major provisions of the Patient Protection and Affordable Care Act are phased in over the next five years.

20 Jul 2010

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Here are highlights from the July issue of Mayo Clinic Women's HealthSource. You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required.

20 Jul 2010

Abortion fight again heats up over high-risk pools, other health reform news

Anti-abortion activists have "scored a victory" after a decision last week by the Obama administration to not allow the new high-risk pools in America to cover most abortions, The Associated Press reports.

20 Jul 2010

Encorium CRO acquires Progenitor

Encorium Group, Inc., a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that it has acquired Progenitor Holdings AG, a corporation organized in Switzerland and its wholly-owned subsidiaries organized in Mexico, Panama, Argentina, Chile, Switzerland, India and Hong Kong for cash and stock valued at EURO 1.7 million, plus earn-out consideration of cash and stock with a value of up to EURO 1.5 million.

19 Jul 2010

Novo Nordisk recruits 60,000th patient in world's largest observational study in insulin therapy

From Novo Nordisk 19 Jul 2010

Over-expression of CIB1 protein triggers biochemical processes that lead to cardiac hypertrophy: Study

Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death.

19 Jul 2010

Tet 1 protein helps stem cells renew themselves and stay pluripotent: Researchers

Take a skin cell from a patient with Type 1 diabetes. Strip out everything that made it a skin cell, then reprogram it to grow into a colony of pancreatic beta cells. Implant these into your patient and voilà! She's producing her own insulin like a pro.

19 Jul 2010

AMPK may regulate epigenetic mechanism: Research

AMP-activated protein kinase, or AMPK, is a master regulator protein of metabolism that is conserved from yeast to humans. When a cell is low on fuel, AMPK shuts down processes that use energy and turns on processes that produce energy.Biologists have been studying how AMPK works for several decades and know that once it is activated, AMPK turns on a large number of genes by passing the "make more energy" message through numerous signaling cascades in the cell. What was not known, until now, was that AMPK also works via an epigenetic mechanism to slow down or stop cell growth.

17 Jul 2010

Endocrinology News and Research

Latest Endocrinology News and Research

Scientists find way to block androgens, halt tumor progression in prostate cancer

Lannett's ANDA for Phentermine Hydrochloride Blue/White Seed Capsules receives FDA approval

FDA accepts MannKind's resubmission of AFREZZA NDA, sets PDUFA action date

Forest Laboratories reports first-quarter diluted EPS of $0.39

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Johnson & Johnson second-quarter sales increase 0.6% to $15.3 billion

More than half of parents interested in using at-home personal genetic testing for their children: Poll

Researchers reveal findings on restricted lineage of iPS cells

Michelangelo hides image of human brainstem in 'Separation of Light from Darkness' panel

Jinfiniti Biosciences moves from clinical studies to developing biomarkers

Novo Nordisk completes patient enrollment in A1chieve study for type 2 diabetes management

Scientists find major shortcomings in assessing CVD risk in HIV patients

Responding to access-to-care challenges: Ideas from a rural doctor, a Washington, D.C. hospital

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Abortion fight again heats up over high-risk pools, other health reform news

Encorium CRO acquires Progenitor

Novo Nordisk recruits 60,000th patient in world's largest observational study in insulin therapy

Over-expression of CIB1 protein triggers biochemical processes that lead to cardiac hypertrophy: Study

Tet 1 protein helps stem cells renew themselves and stay pluripotent: Researchers

AMPK may regulate epigenetic mechanism: Research

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Endocrinology News and Research

Latest Endocrinology News and Research

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in